UK - The £400m Roche Products Pension Fund has lambasted consultants Hewitt Bacon & Woodrow (HB&W) and has decided to sever a 24 year relationship with the firm.
Secretary to the fund for the pharmaceuticals company Douglas Ross said that the decision to replace Hewitt Bacon & Woodrow - which formed part of a “good practice” review - was driven by dissatis...
To continue reading this article...
Join Professional Pensions
- Unlimited access to real-time news, analysis and opinion from the industry
- Receive our in-depth monthly magazine in either print or digital format
- Access our Sustainable Investment Hub covering news and opinion from thought leaders in the ESG space
- Receive important and breaking news stories selected by the Editors in our daily newsletter
- Hear from industry experts and other forward-thinking leaders
- Receive a monthly members-only newsletter with exclusive opinion pieces from leading industry experts and a feature from the magazine in advance of its release date